The cost of asthma medicines

Helen K. Reddel, Kirsty Lembke, Nicholas J. Zwar

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

Most adults and adolescents with asthma require a preventer inhaler. In Australia these patients are often prescribed a combination inhaler containing a corticosteroid and a long-acting beta2agonist. These combination inhalers increase the cost of treatment for patients and for government and may not provide extra benefit. Many patients can control their asthma using an inhaled corticosteroid alone for prevention of symptoms and flare-ups. Most of the benefits of inhaled corticosteroids are obtained at low doses. To achieve these benefits it is important to check that the patient is using their inhaler correctly and regularly. Shared decision making includes discussing the options for treatment. Offering a more affordable preventer regimen could aid adherence and lead to improved outcomes.

Original languageEnglish
Pages (from-to)34-36
Number of pages3
JournalAustralian Prescriber
Volume41
Issue number2
DOIs
Publication statusPublished - Apr 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'The cost of asthma medicines'. Together they form a unique fingerprint.

Cite this